Objective To examine associations between baseline anxiety and depression and
occurrence of ICD shocks and risk of mortality in patients with an implantable cardioverter …

Large-scale implantable cardioverter defibrillator (ICD) trials have unequivocally shown a
reduction in mortality in appropriately selected patients with heart failure and depressed left …

Background Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia
pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood …

Aims Although most implantable cardioverter-defibrillator (ICD) patients cope well, fears
about receiving ICD shocks have been identified as a major determinant of psychological …

Abstract Aims The Anxiety‐CHF (Anxiety in patients with Chronic Heart Failure) study
investigated heart‐focused anxiety (HFA, with the dimensions fear, attention, and avoidance …

Aims Anxiety, depression, and reduced quality of life (QoL) are common in patients with
implantable cardioverter-defibrillators (ICDs). Treatment options are limited and insufficiently …

Objectives To determine (1) the frequency and course of anxiety disorders in patients with
implantable cardioverter defibrillators (ICDs),(2) the predictors of anxiety,(3) the treatment …

Interoceptive experiences are characterized by heightened physiological and psychological
states, particularly when homeostatic deviations occur in response to threats—or potential …

Aims To examine the effect on patients' lives of implantable cardioverter defibrillator
implantation and their experiences of worry about death. Design A descriptive …

Background: Although the implantable cardioverter defibrillator (ICD) has a survival benefit
for the prevention of sudden cardiac death, ICD recipients commonly experience emotional …